RCE.ai, an innovative artificial intelligence (AI) based medical technology company, is dedicated to early heart attack detection.

We have revolutionized the monitoring of cardiac injury by introducing a non-invasive infrared-based wearable. Our proprietary transdermal approach, enhanced with deep learning techniques, analyzes and associates unique optical signatures with cardiac conditions in real-time. This AI coupled transdermal approach enables the potential application of our platform technology in various emergency care settings and remote monitoring applications.

Presently, we are engaged in clinical studies to optimize our product for clinical use. It’s important to note that RCE.ai’s technology is not yet FDA approved and is not available for sale in the US.